Paul Chipperton

Fero International, Inc. is a Canadian company founded in 2020 that aims to improve lives through innovation in the development and deployment of rapid deployment modular infrastructure, medical technology solutions, and disaster relief products. The company is based in Hamilton, Canada, and has subsidiaries in Canada. The company's products are primarily intended to address circumstances of human crises, such as healthcare capacity crises, national defense programs, disaster event crises, access to affordable and safe housing crises, and school capacity and air quality crises. Fero prioritizes the adoption of good corporate governance practices to support sustainable building and manufacturing methods for Fero designed products. The company was founded by Vince DiCristofaro, Sabrina Fiorellino, Alex Scopacasa, and Sabrina Fiorellino has been the CEO since incorporation.

Mperia Therapeutics, Inc. provides biotechnology services. It specializes in CD36 receptor, macrophage-driven inflammation and atherosclerosis. The company was founded by Ong Huy and is headquartered in Montréal, Canada.

Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.

InDanio Bioscience, Inc. operates as drug discovery company. The company was founded by Jens Tiefenbach and Henry Krause and is headquartered in Toronto, Canada.

Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada.